Ready, our operational intelligence and workforce readiness platform, received a very warm welcome from the clinical trials industry at the DIA 2019 Global Annual Meeting.
During the Meeting, I was invited to join PharmaVoice to discuss how Ready analyzes behavioral data to enable Sponsors, CROs, and other trial stakeholders to evaluate and improve the readiness of their workforce and sites.
The video below includes highlights from our discussion.
If you are interested in learning more about Ready and how ArcheMedX is mitigating trial risk, please contact our team to schedule a capabilities presentation or demo.
Thank you again to Taren Grom and the PharmaVoice team for sharing this interview.
Related Post
Episode 2: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The earliest signs of trial risk may appear before the first patient is ever enrolled.…
ArcheMedX Team
Introducing The Human Side of Clinical Trials
A new conversation about clinical trial performance starts here. Published by Applied Clinical Trials and…
ArcheMedX Team
AI Will Not Close the Readiness Gap in Clinical Trials. It Will Expose It.
The risk in an AI-first trial is not that teams use the tools. It is…
